TY - JOUR
T1 - Establishing an Integrative Oncology Service
T2 - Essential Aspects of Program Development
AU - Lacey, Judith
AU - Huston, Alissa
AU - Lopez, Gabriel
AU - Vozmediano, Julia Ruiz
AU - Lam, Chun Sing
AU - Narayanan, Santhosshi
AU - Lu, Weidong
AU - Wolf, Ursula
AU - Subbiah, Ishwaria M.
AU - Richard, Patrick
AU - Lopez, Ana Maria
AU - Rao, Santosh
AU - Frenkel, Moshe
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2024
Y1 - 2024
N2 - Purpose of Review: Over the last 2 decades, integrative oncology (IO) has seen exponential growth within cancer care. It aims to combine evidence-based complementary therapies with conventional treatments to improve the well-being and quality of life for individuals dealing with cancer. The proliferation of integrative medicine programs in major cancer centers globally reflects varying approaches shaped by cultural, demographic, and resource-based factors. Recent Findings: Drawing upon the expertise of leaders in IO from the Society for Integrative Oncology (SIO) Clinical Practice Committee, this manuscript serves as a practical guide for establishing an IO practice. Collating insights from diverse professionals, including oncologists, integrative oncologists, supportive care physicians, researchers, and clinicians, the paper aims to provide a comprehensive roadmap for initiating and advancing IO services. The primary objective is to bridge the gap between conventional cancer care and complementary therapies, fostering a patient-centric approach to address the multifaceted challenges encountered by individuals with cancer. Summary: This paper delineates several key sections elucidating different aspects of IO practice. It delves into the core components necessary for an IO service’s foundation, outlines the initial medical consultation process, and presents crucial tools essential for successful consultations. By consolidating insights and expertise, this manuscript seeks to facilitate the integration of IO into mainstream cancer care, ultimately enhancing patient outcomes and experiences.
AB - Purpose of Review: Over the last 2 decades, integrative oncology (IO) has seen exponential growth within cancer care. It aims to combine evidence-based complementary therapies with conventional treatments to improve the well-being and quality of life for individuals dealing with cancer. The proliferation of integrative medicine programs in major cancer centers globally reflects varying approaches shaped by cultural, demographic, and resource-based factors. Recent Findings: Drawing upon the expertise of leaders in IO from the Society for Integrative Oncology (SIO) Clinical Practice Committee, this manuscript serves as a practical guide for establishing an IO practice. Collating insights from diverse professionals, including oncologists, integrative oncologists, supportive care physicians, researchers, and clinicians, the paper aims to provide a comprehensive roadmap for initiating and advancing IO services. The primary objective is to bridge the gap between conventional cancer care and complementary therapies, fostering a patient-centric approach to address the multifaceted challenges encountered by individuals with cancer. Summary: This paper delineates several key sections elucidating different aspects of IO practice. It delves into the core components necessary for an IO service’s foundation, outlines the initial medical consultation process, and presents crucial tools essential for successful consultations. By consolidating insights and expertise, this manuscript seeks to facilitate the integration of IO into mainstream cancer care, ultimately enhancing patient outcomes and experiences.
KW - Cancer care
KW - Complementary medicine
KW - Integrative oncology
KW - Patient-centered care
KW - Practice guidelines
KW - Supportive care
UR - http://www.scopus.com/inward/record.url?scp=85185131578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85185131578&partnerID=8YFLogxK
U2 - 10.1007/s11912-024-01504-x
DO - 10.1007/s11912-024-01504-x
M3 - Review article
C2 - 38358637
AN - SCOPUS:85185131578
SN - 1523-3790
JO - Current oncology reports
JF - Current oncology reports
ER -